ClinicalTrials.gg
Not yet recruitingNCT07847320Updated Sep 29, 2026

Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series

An observational study in Spine Fracture, Osteoporosis and Spondylitis, Ankylosing, sponsored by Diakonie-Klinikum Stuttgart. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Diakonie-Klinikum Stuttgart · Observational

How we know

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
23
Ages
18 Years and older
Sex
All
01

Study summary

Retrospective observational

Read the detailed description

Retrospective observational study of B3 spine fractures

02

Conditions studied

  • Spine Fracture
  • Osteoporosis
  • Spondylitis, Ankylosing

Keywords

  • B3 fractures
  • spine fractures
03

In context

Spinal Fractures

144 studies on the registry are indexed under Spinal Fractures; 24 are open to participants now.

This study's planned enrollment of 23 is below the median of 93 across 55 observational studies indexed under Spinal Fractures.

Browse Spinal Fractures studies →

Lead sponsor

Diakonie-Klinikum Stuttgart is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with ankylozing spondylitis and B3 spine fractures

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients were eligible if they were aged 18 years or older
  • Had a documented diagnosis of ankylosing spondylitis
  • Had an imaging-confirmed AO Spine B3 fracture,
  • Underwent posterior instrumented stabilization.

Exclusion criteria

Exclusion Criteria:

  • Patients managed non-operatively
  • Patients with spondylodiscitis, primary or neoplasia, or congenital spinal anomalies were excluded.
  • Patients with insufficient data for the predefined variables or without follow-up to the primary endpoint were excluded
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
23 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Complications

    Clavien-Dindo classification for complications

    Time frame: 12 months

Secondary outcomes

  1. Hardware related complications

    Complications like screw losening, screw fracture, etc

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kohler FC, Schenk P, Bechstedt-Schimske M, Ullrich BW, Klauke F, Hofmann GO, Mendel T. Open versus minimally invasive fixation of thoracic and lumbar spine fractures in patients with ankylosing spinal diseases. Eur J Trauma Emerg Surg. 2022 Jun;48(3):2297-2307. doi: 10.1007/s00068-021-01756-3. Epub 2021 Aug 6. PubMed 34357408 ↗
  • Westerveld LA, van Bemmel JC, Dhert WJ, Oner FC, Verlaan JJ. Clinical outcome after traumatic spinal fractures in patients with ankylosing spinal disorders compared with control patients. Spine J. 2014 May 1;14(5):729-40. doi: 10.1016/j.spinee.2013.06.038. Epub 2013 Aug 27. PubMed 23992936 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartEst.
Sep 20, 2026
Primary completionActual
Sep 20, 2026
CompletionEst.
Sep 20, 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07847320
Lead sponsor
Diakonie-Klinikum Stuttgart
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Sep 20, 2026 (estimated)
Primary completion
Sep 20, 2026
Completion
Sep 20, 2026 (estimated)
Last update
Sep 29, 2026

Study contacts

Edgar Santos, PD. Dr. med
Contact
edgar.santos@diak-stuttgart.de
+4917661510746

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion